Organon & Co. (OGN)$13.43
Market Cap: 2.27 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Organon & Co. (OGN).
HEALTHCARE
DRUG MANUFACTURERS - GENERAL
DCF ready
Valuation
19.2x
EV/FCF, 5.2% FCF yield
Quality
2.0%
ROIC, 8.7% FCF margin
Growth
-1.0%
5Y sales (revenue) CAGR
Balance sheet
11.5x
Debt/equity, 1.8x current ratio
Superinvestors
1
Top: Kahn Brothers Group (5.9%)
Strengths to research
- Return on equity is strong at 24.9%.
Watchouts
- Five-year revenue trend is negative at -1.0%.
- Debt/equity is high at 11.5x.
Annual data: 7 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for OGN.
Grade F
18
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| OGN Target | Organon & Co. | $2.3B | 18.7x | 19.2x | 2.0% | -1.0% | 8.7% | 53.3% | N/A | N/A |
| NAMS | Newamsterdam Pharma Co Nv | $2.2B | -20.6x | -11.7x | -29.7% | N/A | -657.8% | N/A | N/A | N/A |
| ACHC | Acadia Healthcare Co. | $2.1B | -1.9x | -10.2x | -24.8% | 9.7% | -13.3% | N/A | N/A | N/A |
| PGNY | Progyny Inc. | $2.0B | 38.3x | 9.9x | 11.3% | 30.2% | 14.9% | 23.6% | -1.2x | N/A |
| IMVT | Immunovant Inc. | $2.6B | -12.3x | -4.1x | -59.3% | N/A | N/A | N/A | N/A | N/A |
| LIVN | LivaNova PLC | $2.0B | -16.6x | 9.9x | -15.4% | 8.2% | 12.5% | 67.7% | -1.1x | N/A |
| ENOV | Enovis Corp. | $2.0B | -1.2x | 161.2x | -42.5% | 14.9% | 0.9% | 59.8% | 5.7x | N/A |
| TVTX | Travere Therapeutics Inc. | $1.9B | -153.2x | 47.9x | -22.2% | 19.9% | 7.7% | N/A | N/A | N/A |
| QDEL | QuidelOrtho Corp. | $1.9B | -0.7x | -53.0x | -24.5% | 10.4% | -3.0% | N/A | N/A | N/A |
Financial Charts
No financial data available for OGN (annual).
1 superinvestors own OGN
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Kahn Brothers Group Kahn Brothers Group | 5,536,993 | $33M | 5.88% | 0.0% |